Regional Monitoring EECA
by ECUO PLWH
Regional Monitoring EECA
Showing 1-22 of 22 items.
| # | Country | Source of financing | Manufacturer | Tradename | INN | Form | Price per unit ($) | Units in purchase | Units in package | Price per package ($) | Packages in purchase | Price per purchase ($) | Distributor | Year | Purchase date | Delivery date | Registered | In the list of main (vital) medications | WHO prequalification |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Republic of Belarus | Global Fund | Emcure Pharmaceuticals Ltd. | Atazanavir (ATV) | 300mg caps | 0.5667 | 4320 | 30 | 17 | 144 | 2448 | IDA Foundation | 2015 | 2015-12-22 | 2016-04-14 | No | No | Not specified | |
| 2 | Republic of Belarus | Global Fund | Emcure Pharmaceuticals Ltd. | Atazanavir (ATV) | 300mg caps | 0.5667 | 15630 | 30 | 17 | 521 | 8857 | UNDP/UNICEF | 2016 | No | No | Not specified | |||
| 3 | Georgia | Global Fund | Emcure Pharmaceuticals Ltd. | Atazanavir (ATV) | 300mg caps | 0.6 | 48600 | 30 | 18 | 1620 | 29160 | partnership for supply. chain management (PFSCM) | 2015 | No | Yes | Not specified | |||
| 4 | Republic of Moldova | Global Fund | Emcure Pharmaceuticals Ltd. | Atazanavir (ATV) | 300mg caps | 0.6983 | 5010 | 30 | 20.95 | 167 | 3498.65 | IDA Foundation | 2016 | Not specified | Not specified | Not specified | |||
| 5 | Republic of Moldova | Global Fund | Emcure Pharmaceuticals Ltd. | Atazanavir (ATV) | 300mg caps | 0.6983 | 5010 | 30 | 20.95 | 167 | 3498.65 | IDA Foundation | 2015 | Not specified | Yes | Not specified | |||
| 6 | Russian Federation | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 200mg caps | 1.6 | 511500 | 60 | 96 | 8525 | 818400 | 2016 | Yes | Yes | Not specified | |||
| 7 | Russian Federation | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 150mg caps | 1.6 | 341100 | 60 | 96 | 5685 | 545760 | 2016 | Yes | Yes | Not specified | |||
| 8 | Russian Federation | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 150mg caps | 1.7975 | 5537820 | 60 | 107.85 | 92297 | 9954231 | 2015 | Not specified | Not specified | Not specified | |||
| 9 | Russian Federation | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 300mg caps | 3.603 | 111030 | 30 | 108.09 | 3701 | 400041.09 | 2015 | Not specified | Not specified | Not specified | |||
| 10 | Russian Federation | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 200mg caps | 2.137 | 1038960 | 60 | 128.22 | 17316 | 2220257.5 | 2016 | Yes | Yes | Not specified | |||
| 11 | Russian Federation | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 200mg caps | 2.137 | 692640 | 60 | 128.22 | 11544 | 1480171.62 | 2016 | Yes | Yes | Not specified | |||
| 12 | Russian Federation | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 200mg caps | 2.3747 | 10007940 | 60 | 142.48 | 166799 | 23765522 | 2015 | Not specified | Not specified | Not specified | |||
| 13 | Republic of Poland | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 300mg caps | 11.6297 | 18000 | 30 | 348.89 | 600 | 209334 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 14 | Republic of Latvia | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 300mg caps | 13.0957 | 30 | 30 | 392.87 | 1 | 392.87 | 2015 | Not specified | Not specified | Not specified | |||
| 15 | Republic of Poland | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 200mg caps | 6.6152 | 3000 | 60 | 396.91 | 50 | 19845.5 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 16 | Republic of Poland | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 150mg caps | 6.8198 | 6600 | 60 | 409.19 | 110 | 45010.9 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 17 | Republic of Poland | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 300mg caps | 14.0183 | 72000 | 30 | 420.55 | 2400 | 1009320 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 18 | Republic of Latvia | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 300mg caps | 14.8337 | 67260 | 30 | 445.01 | 2242 | 997712.44 | National Health Service (NHC) | 2016 | Not specified | Not specified | Not specified | ||
| 19 | Republic of Poland | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 200mg caps | 7.5 | 13800 | 60 | 450 | 230 | 103500 | 2015 | Not specified | Not specified | Not specified | |||
| 20 | Republic of Poland | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 300mg caps | 15.4167 | 27000 | 30 | 462.5 | 900 | 416250 | 2015 | Not specified | Not specified | Not specified | |||
| 21 | Republic of Poland | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 300mg caps | 15.4167 | 3000 | 30 | 462.5 | 100 | 46250 | 2015 | Not specified | Not specified | Not specified | |||
| 22 | Republic of Poland | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 300mg caps | 15.4167 | 162000 | 30 | 462.5 | 5400 | 2497500 | 2015 | Not specified | Not specified | Not specified |